Amgen to sell cholesterol drug at 60% discount to cash-paying US patients
PositiveFinancial Markets

Amgen has announced a significant 60% discount on its cholesterol drug for cash-paying patients in the U.S. This move is crucial as it aims to make essential medication more affordable for those who may struggle with high healthcare costs. By reducing the price, Amgen is not only helping patients manage their cholesterol levels but also addressing the broader issue of drug affordability in the U.S. healthcare system.
— Curated by the World Pulse Now AI Editorial System